General MedicationsINJECTIONGeneric

MORPHINE SULFATE

Standard Dose

15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview MORPHINE SULFATE is listed in Drugs@FDA under application 202515 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient MORPHINE SULFATE Form and strength INJECTABLE;INJECTION - 15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor HOSPIRA INC Submission history Latest submission status date: 2025-12-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview MORPHINE SULFATE is listed in Drugs@FDA under application 202515 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MORPHINE SULFATE Form and strength INJECTABLE;INJECTION - 15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor HOSPIRA INC Submission history Latest submission status date: 2025-12-22 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.